Practical guidance for the use of cyclosporine ophthalmic solutions in the management of dry eye disease

Rodrigo Carlos de Oliveira, Steven E WilsonCole Eye Institute, Cleveland Clinic, Cleveland, OH, USAAbstract: Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: de Oliveira RC, Wilson SE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/6529299cf06f49c3b1e22a3f1922b40e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:Rodrigo Carlos de Oliveira, Steven E WilsonCole Eye Institute, Cleveland Clinic, Cleveland, OH, USAAbstract: Dry eye disease (DED) is a multifactorial disease of ocular surface and tear film, and is a common disorder treated by eye care providers. It is well established that ocular surface inflammation has an important role in the pathophysiology of DED and that anti-inflammatory cyclosporine A (CsA) improves the treatment outcomes of most patients with DED. The purpose of this review is to provide guidance for practitioners in the use of topical CsA for the management of DED to improve patient satisfaction and the quality of life.Keywords: keratoconjunctivitis sicca, dry eye disease, cyclosporine A